Here are four headlines to know on orthopedic medtech company Stryker, as reported by Becker’s since June 2:
- During the second quarter, Stryker reached 2 million procedures with Mako robotics.
- The company grew its orthopedic sales by 2% during the second quarter.
- Stryker secured FDA clearance for its Incompass total ankle system to treat patients whose ankle joints have been damaged by severe rheumatoid, post-traumatic or degenerative arthritis.
- Stryker was included on the 71st Fortune 500, ranking in the top 25 healthcare companies.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
